Cite
MLA Citation
Hendrik Neubert et al.. “2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs).” Bioanalysis, vol. 9, 2017, pp. 1895–1912. http://access.bl.uk/ark:/81055/vdc_100140350723.0x000003